LifeMD Inc
LFMD
查看详细走势图
3.250USD
+0.020+0.62%
交易中 （美东）报价延迟15分钟
151.40M总市值
亏损市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
+0.62%
5天
-4.41%
1月
-15.58%
6月
-77.98%
今年开始到现在
-34.34%
1年
-35.52%
查看详细走势图
TradingKey LifeMD Inc股票评分
单位: USD 更新时间: 2025-12-19操作建议
LifeMD Inc当前公司基本面数据相对健康，增长潜力很大。当前估值合理，在医疗设备与耗材行业排名78/208位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价9.25。中期看，股价处于下降通道。近一个月，市场表现非常差，但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
LifeMD Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
8
位分析师
买入
评级
9.250
目标均价
+154.12%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
LifeMD Inc亮点
亮点风险
LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
业绩高增长
公司营业收入稳步增长，连续3年增长78.48%
估值合理
公司最新PE估值-12.83，处于3年历史合理位
机构加仓
最新机构持股24.14M股，环比增加10.27%
PRFDX持仓
明星投资者PRFDX持仓，最新持仓市值3.48K
活跃度增加
近期活跃度增加，过去20天平均换手率1.53
LifeMD Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
LifeMD Inc简介
LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
公司代码LFMD
公司LifeMD Inc
CEOSchreiber (Justin)
网址https://lifemd.com/
常见问题
LifeMD Inc(LFMD)的当前股价是多少？
LifeMD Inc(LFMD)的当前股价是 3.250。
LifeMD Inc的股票代码是什么？
LifeMD Inc的股票代码是LFMD。
LifeMD Inc股票的52周最高点是多少？
LifeMD Inc股票的52周最高点是15.840。
LifeMD Inc股票的52周最低点是多少？
LifeMD Inc股票的52周最低点是3.250。
LifeMD Inc的市值是多少？
LifeMD Inc的市值是151.40M。
LifeMD Inc的净利润是多少？
LifeMD Inc的净利润为-21.99M。
现在LifeMD Inc(LFMD)的股票是买入、持有还是卖出？
根据分析师评级，LifeMD Inc(LFMD)的总体评级为买入，目标价格为9.250。
LifeMD Inc(LFMD)股票的每股收益（EPS TTM）是多少
LifeMD Inc(LFMD)股票的每股收益（EPS TTM）是-0.252。
相关品种
-0.43%
+0.65%
+1.31%
+1.43%
+1.41%
+0.60%
+0.55%
-0.84%
-0.12%
+0.48%
+0.84%
+1.14%
-0.53%
+1.11%
-0.30%
+1.23%
+0.84%
+1.16%
+0.54%
+1.26%
